Publications

484 publications

Enter search criteria

Keyword

Fill in keyword(s) to narrow your search.

Period

Last 7 days Last 30 days Last 365 days Specific period

Period from

The start date was not recognised. Please enter the date in the following format: DD-MM-YYYY.

Period up to

The end date was not recognised. Please enter the date in the following format: DD-MM-YYYY.

The end date may not occur before the start date.

Type

You can select a specific type of a publication you are looking for, such as press releases or speeches

Sort by:

Date
Relevance

Zinnige Zorg room for improvement report - Appropriate use of expensive medicines in cases of metastatic renal cell carcinoma

Within the framework of the Zinnige Zorg Programme, Zorginstituut Nederland systematically assesses the Dutch minimal and ...

Report | 07-12-2017
Idebenone (Raxone®) for the treatment of Leber’s Hereditary Optic Neuropathy (LHON)

The National Health Care Institute has carried out an assessment of the medicinal product idebenone (Raxone®). Idebenone ...

Report | 20-10-2017
Programme ‘Outcome Information for Shared Decision-Making’ - factsheet

Publication | 19-10-2017
Project: ‘ICHOM as an accelerator for outcome information’ - factsheet

Publication | 19-10-2017
Glycerol phenylbutyrate (Ravicti®) for the treatment of urea-cycle disorders

The National Health Care Institute has carried out an assessment of the medicinal product glycerol phenylbutyrate (Ravicti®) for ...

Report | 12-09-2017
Zinnige Zorg room for improvement report - In-depth phase neoplasms: care during the final stage of life of patients with incurable intestinal or lung cancer

The final stage of life is one in which a patient is of an advanced age or has a disease and/or is in a phase of a disease that ...

Report | 01-09-2017
Cetuximab (Erbitux®) for the treatment of metastatic colorectal cancer

The National Health Care Institute has carried out a re-assessment of the medicinal product cetuximab (Erbitux®), whereby they ...

Report | 26-06-2017
Acarizax® in cases of allergic rhinitis due to house dust mite

The National Health Care Institute carried out an assessment of whether the medicinal product Acarizax® is interchangeable with a ...

Report | 26-06-2017
A paradigm shift in perception, learning and action - core of the second advice of the Committee Innovation Health Care Professions & Education

Translation of the core of the second advice of The Committee Innovation Health Care Professions & Education. This report is a ...

Report | 18-05-2017
Tenofovir alafenamide (Vemlidy®) for the treatment of chronic hepatitis B infection

The National Health Care Institute carried out an assessment of the medicine tenofovir alafenamide (Vemlidy®). Based on the ...

Report | 26-04-2017

Publications

484 publications

Zinnige Zorg room for improvement report - Appropriate use of expensive medicines in cases of metastatic renal cell carcinoma

Idebenone (Raxone®) for the treatment of Leber’s Hereditary Optic Neuropathy (LHON)

Programme ‘Outcome Information for Shared Decision-Making’ - factsheet

Project: ‘ICHOM as an accelerator for outcome information’ - factsheet

Glycerol phenylbutyrate (Ravicti®) for the treatment of urea-cycle disorders

Zinnige Zorg room for improvement report - In-depth phase neoplasms: care during the final stage of life of patients with incurable intestinal or lung cancer

Cetuximab (Erbitux®) for the treatment of metastatic colorectal cancer

Acarizax® in cases of allergic rhinitis due to house dust mite

A paradigm shift in perception, learning and action - core of the second advice of the Committee Innovation Health Care Professions & Education

Tenofovir alafenamide (Vemlidy®) for the treatment of chronic hepatitis B infection

Go to